Pharmacy News

Image description

FDA approves ovarian cancer drug

Tesaro’s Zejula is an oral, once-daily poly (ADP-ribose) polymerase (PARP) inhibitor, for the maintenance treatment of women with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response (CR or PR) to platinum-based chemotherapy.

Image description

FDA fast-tracks Genentech’s Rituxan

Drug is intended for the treatment of pemphigus vulgaris, a painful, disfiguring and potentially fatal autoimmune disease characterized by progressive blistering of skin and/or mucous membranes.

Image description

FDA approves Lupin generic

Tobramycin Inhalation Solution USP, 300 mg/5 ml, a generic version of Novartis Pharmaceuticals’ TOBI 300 mg/5 ml, is indicated for the management of cystic fibrosis patients with P. aeruginosa.

Image description

FDA approves Parkinson’s drug

Newron Pharmaceuticals’ Xadago was approved as an add-on treatment for patients with Parkinson’s disease who are currently taking levodopa/carbidopa and experiencing “off” episodes.